79028077 - PAIONEERING

Information

• Trademark
• 79028077

• Source

• Serial Number

  79028077

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  May 11, 2006
  18 years ago

• Transaction Date

  December 09, 2016
  8 years ago

• Status Date

  May 11, 2016
  8 years ago

• Published for Opposition Date

  November 04, 2008
  16 years ago

• Location Date

  August 12, 2009
  15 years ago

• Status Code

  402

• Current Location

  TTAB

  Employee Name

  LOWRY, LEIGH A

• Attorney Docket Number

  S11796

  Attorney Name

  Gary D. Krugman

  Law Office Assigned Location Code

  M60

• Owners

  • PAION DEUTSCHLAND GMBH

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• GS0011: Research reagents; biochemical preparations for scientific purposes
• GS0051: Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutraceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents; medical and clinical diagnostic reagents for clinical or medical laboratory use; pharmaceutical preparations, namely, thrombolytic, fibrinolytic anti-coagulative, antithrombotical and neuroprotective substances for the treatment of blood clotting, cell protection and cell regeneration; products from biotechnological methods, namely, proteins for therapeutic and diagnostic use in the treatment and diagnosis of blood clotting disorders
• GS0101: Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting blood specimen analysis of the human blood clotting system and for conducting medical diagnostic tests in the nature of medical apparatus for diagnosing suspected heart attacks, strokes, thrombosis, circulations and vascular disorders, embolisms, kidney failures, liver damages, infections, viral infections, sepsis, inflammatory and neuronal disorders
• GS0411: Educational services, namely, providing seminars, educational exhibitions, correspondence courses, colloquiums, conferences, congresses, and workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, gendiagnostics
• GS0421: Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, performing pre-clinical studies, quality control; preparation of technical expert opinions in the field of chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry, product research and development of medical devices and pharmaceutical preparations; and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the areas the treatment and diagnosis of stroke, neuron damage, thrombotic diseases, heart diseases including heart failure, circulation disorders, gene expression analysis, namely, protogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins, diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries; performance of pre-clinical studies, namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products; bio-chemical and biotechnological research and development for others, namely, bio-technical research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment, scientific research on and development of medical diagnostic equipment and pharmaceutical preparations and products for the treatment of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others in the fields of prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment
• PM0001: PIONEERING

Case File Event Statements

• 12/9/2016 - 8 years ago

  54 - NOTIFICATION OF EFFECT OF ABANDONMENT OF INTL REG E-MAILED Type: DENA

• 12/8/2016 - 8 years ago

  53 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH

• 12/13/2013 - 11 years ago

  52 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 10/2/2010 - 14 years ago

  51 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINT

• 8/12/2010 - 14 years ago

  50 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 8/12/2010 - 14 years ago

  49 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 12/1/2009 - 15 years ago

  48 - OPPOSITION TERMINATED NO. 999999 Type: OP.T

• 12/1/2009 - 15 years ago

  47 - OPPOSITION DISMISSED NO. 999999 Type: OP.D

• 8/12/2009 - 15 years ago

  46 - ABANDONMENT NOTICE MAILED - INTER PARTES DECISION Type: MAB4

• 8/12/2009 - 15 years ago

  45 - ABANDONMENT - AFTER INTER PARTES DECISION Type: ABN4

• 8/12/2009 - 15 years ago

  44 - OPPOSITION TERMINATED NO. 999999 Type: OP.T

• 8/12/2009 - 15 years ago

  43 - OPPOSITION SUSTAINED NO. 999999 Type: OP.S

• 7/18/2009 - 15 years ago

  42 - REFUSAL PROCESSED BY IB Type: RFNT

• 7/18/2009 - 15 years ago

  41 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 6/23/2009 - 15 years ago

  40 - IRREGULARITY ON REFUSAL FROM IB Type: IRRF

• 5/6/2009 - 15 years ago

  39 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I

• 5/5/2009 - 15 years ago

  38 - OPPOSITION NOTICE (IB REFUSAL) SENT TO IB Type: OPNS

• 5/5/2009 - 15 years ago

  37 - OPPOSITION NOTICE (IB REFUSAL) CREATED Type: OPNC

• 1/15/2009 - 15 years ago

  36 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I

• 11/24/2008 - 16 years ago

  35 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 11/4/2008 - 16 years ago

  34 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/15/2008 - 16 years ago

  33 - NOTICE OF PUBLICATION Type: NPUB

• 10/1/2008 - 16 years ago

  32 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 9/19/2008 - 16 years ago

  31 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/19/2008 - 16 years ago

  30 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 9/19/2008 - 16 years ago

  29 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 9/19/2008 - 16 years ago

  28 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 9/19/2008 - 16 years ago

  27 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 9/19/2008 - 16 years ago

  26 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 9/19/2008 - 16 years ago

  25 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/11/2008 - 16 years ago

  24 - ATTORNEY REVOKED AND/OR APPOINTED Type: ARAA

• 8/11/2008 - 16 years ago

  23 - TEAS REVOKE/APPOINT ATTORNEY RECEIVED Type: REAP

• 8/7/2008 - 16 years ago

  22 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/7/2008 - 16 years ago

  21 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/4/2008 - 16 years ago

  20 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 8/4/2008 - 16 years ago

  19 - ATTORNEY REVOKED AND/OR APPOINTED Type: ARAA

• 8/4/2008 - 16 years ago

  18 - TEAS REVOKE/APPOINT ATTORNEY RECEIVED Type: REAP

• 3/28/2008 - 16 years ago

  17 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 3/13/2008 - 16 years ago

  16 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 3/13/2008 - 16 years ago

  15 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 2/6/2008 - 16 years ago

  14 - FINAL REFUSAL MAILED Type: CNFR

• 2/5/2008 - 16 years ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 5/16/2007 - 17 years ago

  12 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 5/16/2007 - 17 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/16/2007 - 17 years ago

  10 - ASSIGNED TO LIE Type: ALIE

• 4/23/2007 - 17 years ago

  9 - PAPER RECEIVED Type: MAIL

• 11/10/2006 - 18 years ago

  8 - REFUSAL PROCESSED BY IB Type: RFNT

• 10/24/2006 - 18 years ago

  7 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 10/24/2006 - 18 years ago

  6 - REFUSAL PROCESSED BY MPU Type: RFRR

• 10/23/2006 - 18 years ago

  5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 10/22/2006 - 18 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/13/2006 - 18 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 10/13/2006 - 18 years ago

  2 - NEW APPLICATION ENTERED IN TRAM Type: NWAP

• 10/12/2006 - 18 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR